Different types of dialyzer membranes: Does the bio(in)compatibility matter in the treatment of ARF?

Renal Failure

Volumn 18, Issue 3, 1996, Pages 471-479

  Vanholder, R ^a   Lameire, N ^a   Hoste, E ^a   Van Loo, A ^a   Dhondt, A M ^a   Ringoir, S ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID;

ACUTE KIDNEY FAILURE; BIOCOMPATIBILITY; BIOFILTRATION; COMPLEMENT ACTIVATION; CONFERENCE PAPER; HEMODYNAMIC MONITORING; HUMAN; HUMAN CELL; INFECTION RISK; INTENSIVE CARE UNIT; KIDNEY FUNCTION; KIDNEY INJURY; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 0029906298     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229609052818     Document Type: Conference Paper

References (42)

1. Turney JH, Marshall DH, Brownjohn AM, Ellis CM, Parsons FM: The evolution of acute renal failure, 1956-1988. Q J Med 74:83-104, 1990
2. Hakim RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 44:484-494, 1993.
3. Stein JH, Lifschitz MD, Barnes LD: Current concepts on the patho-physiology of acute renal failure. Am J Physiol 234:F171-F181, 1978.
4. Greene EL, Palier MS: Calcium and free radicals in hypoxia/reoxygenation injury of renal epithelial cells. Am J Physiol 266:F13-F20, 1994.
5. Shah SV, Walker PD: Evidence suggesting a role for hydroxyl free radical in glycerol-induced acute renal failure. J Clin Invest 255:F438-F443, 1988.
6. Iaina A, Schwartz D: Renal tubular cellular and molecular events in acute renal failure. Nephron 68:413-418, 1994.
7. Walker PD, Shah SV: Evidence suggesting a role for hydroxyl radical in gentamycin-induced acute renal failure in rats. J Clin Invest 81:334-341, 1988.
8. Palier MS: Renal work, glutathione and susceptibility to free radical-mediated postischemic injury. Kidney Int 33:843-849, 1988.
9. Paller MS: Hemoglobin- and myoglobin-induced acute renal failure in rat: role of iron in nephrotoxicity. Am J Physiol 255:F539-F544, 1988.
10. Palier MS: Effect of neutrophil depletion on ischemic renal injury in the rat. J Lab Clin Med 113:379-386, 1989.
11. Gamelin LM, Zager RA: Evidence against oxidant injury as a critical mediator of postischemic acute renal failure. Am J Physiol 255:F450-F460, 1988.
12. Conger JD, Schultz MF, Miller F, Robmette JB: Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int 46:318-323, 1994.
13. Matthys E, Patton MK, Osgood RW, Venkatachalam MA, Stein JH: Alterations in vascular function and morphology in acute ischemic renal failure. Kidney Int 23:717-724, 1983.
14. Nguyen AT, Lethias C, Zingraff J, Herbelin A, Naret C, Descamps-Latscha B: Hemodialysis membraneinduced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int 28:158-167, 1985.
15. Vanholder R: Biocompatibility issues in hemodialysis. Clin Mat 10:87-133, 1992.
16. -. in posthypoxic injury of renal epithelial cells. Am J Physiol 263:F251-F255, 1992.
17. Kelly KJ, Williams WW, Colvin RB, Bonventre JV: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 91:812-816, 1994.
18. Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacob HS: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59:879-888, 1977.
19. Schulman G, Fogo A, Gung A, Badr K, Hakim R: Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 40:1069-1074, 1991.
20. Linas SL, Whittenburg D, Parsons P, Repine JE: Mild renal ischemia activates primed neutrophils to cause acute renal failure. Kidney Int 42:610-616, 1992.
21. Harris KPG, Schreiner GF, Klahr S: Effect of leukocyte depletion on the function of the post obstructed kidney in the rat. Kidney Int 36:210-215, 1989.
22. Stein JH, Osgood RW, Barnes JL, Reineck HJ, Pinckard RN, McManus LM: The role of complement in the pathogenesis of postischemic renal failure. Miner Electrolyte Metab 11:256-261, 1985.
23. Vanholder R, Ringoir S, Dhondt A, Hakim R: Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 39:320-327, 1991.
24. Vanholder R, Ringoir S: Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 3:1541-1554, 1993.
25. Lewis SL, Van Epps DE: Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis 9:381-395, 1987.
26. Levin NW, Zasuwa G, Dumler F. Effect of membrane type on causes of death in hemodialysis patients. J Am Soc Nephrol 2:335, 1991 (abstract).
27. Hornberger JC, Chernew M, Petersen J, Garber AM: A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 3:1227-1237, 1992.
28. Hakim RM, Wingard RL, Parker RA, Vanholder R, Husni L, Parker TF: Effects of biocompatibility on hospitalizations and infectious morbidity in chronic hemodialysis patients (CHD). J Am Soc Nephrol 5:450, 1994.
29. Schiffi H, Lang SM, König A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 344:570-572, 1994.
30. De Backer WA, Verpooten GA, Borgonjon DJ, Vermeire PA, Lins RR, De Broe ME: Hypoxemia during hemodialysis: effects of different membranes and dialysate compositions. Kidney Int 23:738-743, 1983.
31. Vanholder RC, Pauwels RA, Vandenbogaerde JF, Lamont HH, Van Der Straeten ME, Ringoir SM: Cuprophan reuse and intradialytic changes of lung diffusion capacity and blood gasses. Kidney Int 32:117-122, 1987.
32. Cheung AK, Baranowski RL, Wayman AL: The role of thromboxane in cuprophane-induced pulmonary hypertension. Kidney Int 32:1072-1079, 1987.
33. Ronco C: Backfiltration in clinical dialysis: nature of the phenomenon, mechanisms and possible solutions. Int J Artif Org 13:11-22, 1990.
34. Vanholder R, Van Haecke E, Veys N, Ringoir S: Endotoxin transfer through dialysis membranes: small versus large pore membranes. Nephrol Dial Transplant 7:333-339, 1992.
35. Lonnemann G, Bingel M, Floege J, Koch KM, Shaldon S, Dinarello C: Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int 33:29-35, 1988.
36. Urena P, Herbelin A, Zingraff J, Lair M, Man NK, Descamps-Latscha B, Drüeke T: Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. Nephrol Dial Transplant 7:16-28, 1992.
37. Verresen L, Waer M, Vanrenterghem Y, Michielsen P: Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis. Lancet 336:1360-1362, 1990.
38. Hakim RM, Breilatt J, Lazarus JM, Port FK: Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 311:878-882, 1984.
39. Kranzlin B, Reuss A, Gretz N, Kirschfink M, Ryan CJ, Mujais S: Recovery from ischemic acute renal failure: independence from membrane type. J Am Soc Nephrol 5:460, 1994 (abstract).
40. Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 331:1338-1342, 1994.
41. Liano F, Gallego A, Pascual J, Garcia-Martin F, Teruel JL, Marcen R, Orofino L, Orte L, Rivera M, Gallego N, Quereda C, Ortuno J: Prognosis of acute tubular necrosis: an extended prospectively contrasted study. Nephron 63:21-31, 1993.
42. Vanholder R, Bernaert P, Van Loo A, Lameire N, Ringoir S: Pre-transplant (TP) hemodialysis (HD) with cuprophane (CUP) and/or ultrafiltration (UF) decreases early graft function. J Am Soc Nephrol 5:482, 1994 (abstract).